Trial Details
Not RecruitingBasic Information
| Clinical ID | c2018 |
|---|---|
| Identifier | CTIS2024-517502-28-01 |
| Trial Title | Subcutaneous vedolizumab drug de-escalation using therapeutic drug monitoring in inflammatory bowel disease: a randomized controlled pilot study - NL80854.018.22 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory bowel disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: Entyvio 108 mg solution for injection in pre-filled syringe, Product Code:PRD8036174, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: |
Participant Information
| Sponsor | Amsterdam UMC Stichting |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |